WO2015070394A1 - Method for preparing penem antibiotic intermediate - Google Patents

Method for preparing penem antibiotic intermediate Download PDF

Info

Publication number
WO2015070394A1
WO2015070394A1 PCT/CN2013/087038 CN2013087038W WO2015070394A1 WO 2015070394 A1 WO2015070394 A1 WO 2015070394A1 CN 2013087038 W CN2013087038 W CN 2013087038W WO 2015070394 A1 WO2015070394 A1 WO 2015070394A1
Authority
WO
WIPO (PCT)
Prior art keywords
reaction
chemical formula
compound represented
compound
formula
Prior art date
Application number
PCT/CN2013/087038
Other languages
French (fr)
Chinese (zh)
Inventor
洪浩
马建国
李九远
董长明
张磊
Original Assignee
凯莱英医药集团(天津)股份有限公司
凯莱英生命科学技术(天津)有限公司
天津凯莱英制药有限公司
凯莱英医药化学(阜新)技术有限公司
吉林凯莱英医药化学有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 凯莱英医药集团(天津)股份有限公司, 凯莱英生命科学技术(天津)有限公司, 天津凯莱英制药有限公司, 凯莱英医药化学(阜新)技术有限公司, 吉林凯莱英医药化学有限公司 filed Critical 凯莱英医药集团(天津)股份有限公司
Priority to PCT/CN2013/087038 priority Critical patent/WO2015070394A1/en
Publication of WO2015070394A1 publication Critical patent/WO2015070394A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Definitions

  • the invention relates to the field of synthesis of pharmaceutical intermediates, in particular to a preparation method of a Pein-like antibiotic intermediate. Background technique
  • Pein-type drugs such as meropenem, doripenem and ertapenem are a class of broad-spectrum antibiotics for ⁇ -lactam injection. It is well known that the compound represented by the formula (la) is a card catalyzed by ruthenium.
  • the synthetic route shown in Reaction Scheme 2 is currently widely used.
  • the compound of the formula (la) can be subjected to CDI activation, nucleophilic addition reaction and decarboxylation reaction, and removal of TBS (t-butyl group) by ⁇ -methyl-ADC-8 (4-oxime, compound of formula (V)).
  • Dimethylsilyl hydrazine and the diazotization reaction involving t-decylbenzenesulfonyl azide are conveniently prepared. 0. Am. Chem. Soc, 1980, 102 6161-6163).
  • a difficulty with this route is the preparation of a compound represented by the chiral ⁇ -methyl formula (V).
  • 4-Acetylazetidinone (4AA, a compound of formula (VIII)) is generally used to prepare 4-BMA (reviewed in detail: Tetrahedron, 1996, 52, 33 1 -375).
  • 4-BMA (US53 10897, US4873324, EP230792, reaction formula 3) can be produced in a high yield and high selectivity by an asymmetric hydrogenation reaction.
  • the preparation of the compound of the formula (IX) is difficult.
  • the compound of the formula (XIV) can be obtained by a series of reactions of 4AA by a coupling reaction of isopropylidene methylmalonate, N-silylation and solvolysis of methyl isopropylidene malonate.
  • the acid-catalyzed asymmetric hydrolysis and removal of the protecting group can then give 4-indole at a ⁇ -selectivity of >10:1.
  • a primary object of the present invention is to provide a simple and commercially valuable synthetic route for the preparation of a compound of the formula by a two-step reaction of a compound of formula (II).
  • Another object of the present invention is to provide a high ⁇ -selective method for direct Mannich addition of a compound of the formula (II) using a compound of the formula ⁇ ).
  • the present invention also provides optimum reaction conditions for the Mannich reaction.
  • the present invention provides a process for preparing a penicillin antibiotic intermediate represented by the chemical formula ⁇ ), which comprises the steps shown in Reaction Scheme 7.
  • the compound represented by the chemical formula ⁇ ) is abbreviated as the compound ⁇ ), and the other compounds are also referred to as corresponding abbreviations.
  • TBS tert-butyldimethylsilyl
  • the functional group represented by R 1 includes, but is not limited to, methyl (Me), ethyl (Et), p-nitrobenzyl (PNB), benzyl (Bn), allyl (Allyl), 4-chlorobenzyl, 2-nitrobenzyl, 3-nitrobenzyl, 4-methoxybenzyl;
  • R 2 includes, but is not limited to, acetyl (Ac), benzoyl (Bz);
  • R 2 The functional groups represented by R 2 include, but are not limited to, trimethylsilyl (TMS), tert-butyldimethylsilyl (TBS).
  • TMS trimethylsilyl
  • TBS tert-butyldimethylsilyl
  • the compound of the formula (III) can be easily synthesized by a conventional method.
  • Equation 7 The content in Equation 7 consists essentially of two steps:
  • Step h The compound of the formula ( ⁇ ) is reacted with a compound of the formula ⁇ ) to obtain a compound of the formula (XVI);
  • Step 2 The compound represented by the chemical formula (XVI) is prepared, that is, ⁇ - Methylpenic antibiotic intermediate.
  • Steps 1 and 2 are carried out according to the following reaction conditions:
  • step 1 the reaction can be carried out under a variety of known Lewis acid catalyzed direct Mannich reactions. After the reaction is completed, various methods can be used for post treatment.
  • the Lewis acid used in the Mannich reaction may be any of the existing acids used in the Mannich reaction, including but not limited to titanium tetrachloride (TiCl 4 ), titanium tetrabromide (TiBr 4 ), silicon tetrachloride (SiCl 4 ).
  • lanthanum trichloride LaCl 3
  • zinc chloride ZnCl 2
  • zinc bromide ZnBr 2
  • magnesium chloride MgCl 2
  • boron tribromide BBr 3
  • copper chloride CuCl 2
  • Copper triflate Cu(OTf) 2
  • cuprous triflate CuOTf
  • cuprous iodide Cul
  • boron trichloride BC1 3
  • the molar ratio of the Lewis acid to the compound of the formula (II) is 0.8 to 3.0:1, preferably 1.0 to 1.5: l o If less Lewis acid is used, the reaction cannot be completed.
  • a Lewis base is also present in the reaction of step 1.
  • the Lewis base may be any of the bases currently used in the Mannich reaction, including but not limited to triethylamine, diisopropylethylamine, tri-n-butylamine, tetramethylethylenediamine, 4-methylmorpholine, 1,8-diazabicyclo[5.4.0]undec-7-ene, 1,4-diazabicyclo[2.2.2]octane, 4-dimethylaminopyridine, N-methyl Pyrrolizine, N-methylpiperidine, diethylamine, diisopropylamine, pyrrole, piperidine, hexamethylphosphoric triamide, pyridine, 3-methylpyridine, and combinations thereof. It is preferred to use a tertiary amine therein.
  • the molar ratio of the Lewis base to the compound of the formula (II) is from 1.2 to 4.0:1, preferably
  • the reaction of the step 1 is usually carried out by dissolving the compound of the formula in an organic solvent, cooling, then adding a Lewis acid and a Lewis base, stirring, adding a compound of the formula ( ⁇ ), and then reacting until the end.
  • the solvent includes methylene chloride, 1,2-dichloroacetonitrile, toluene, acetonitrile, tetrahydrofuran, methyl t-butyl ether, 2-methyltetrahydrofuran or a combination thereof.
  • methylene chloride, 1,2-dichloroethane or a combination thereof is used.
  • the solvent is used in an amount of 8 to 30 mL/g based on the compound of the formula ( ⁇ ) (i.e., 8 to 30 mL of the solvent per gram of the compound represented by the formula ( ⁇ ), preferably 12 to 20 mL/g.
  • the molar ratio of the compound of the formula (III) to the compound of the formula ( ⁇ ) is 1.0 to 2.0: 1, preferably 1.2 to 1.5: 1.
  • the reaction temperature in the step 1 is -60 to 10 ° C, preferably -30 to 0 ° C.
  • a suitable temperature for the addition of the Lewis acid and the Lewis base is -60 to 0 ° C, preferably -50 to 30 ° C.
  • the appropriate stirring time before the addition of the compound of the formula (II) should be 10 to 60 minutes, preferably 20 to 30 minutes.
  • a suitable temperature for the addition of the compound of the formula (II) is -60 to 0 ° C, preferably -40 to 20 ° C.
  • a suitable temperature for the reaction is -40 to 10 ° C, preferably -20 to 0 ° C.
  • the reaction will proceed very slowly at lower temperatures.
  • the appropriate reaction time should be within 4 hours and, if possible, the reaction should be completed within 2.5 hours. Longer reaction times result in more impurities and lower yields.
  • the reaction is quenched with an aqueous solution such as aqueous sodium chloride solution, aqueous sodium hydrogencarbonate solution, aqueous sodium dihydrogen phosphate solution, aqueous potassium dihydrogen phosphate solution, aqueous magnesium chloride solution, aqueous calcium chloride solution or purified water, preferably using pure water.
  • an aqueous solution such as aqueous sodium chloride solution, aqueous sodium hydrogencarbonate solution, aqueous sodium dihydrogen phosphate solution, aqueous potassium dihydrogen phosphate solution, aqueous magnesium chloride solution, aqueous calcium chloride solution or purified water, preferably using pure water.
  • concentration of the aqueous solution is a concentration of a common quenching solution, and preferably the mass percentage of the solute may be 5% to 25%.
  • the amount of the quenching solution is 3 to 30 mL/g, preferably 5 to 10 mL/g, based on the compound of the formula ( ⁇ ).
  • the compound of the formula (XVI) obtained in the step 1 can be directly used for the next reaction, or can be further purified, preferably using methanol, methanol-water, ethanol, ethanol-water, acetone, acetone-water, acetonitrile.
  • Solvents such as isopropanol, n-hexanol, n-glycol, toluene, petroleum ether, etc. are purified by recrystallization, more preferably by recrystallization from methanol-water.
  • the amount of the recrystallization solvent is from 3 to 20 mL/g, preferably from 4 to 8 mL/g, based on the compound of the formula (II). Using more solvent will reduce the yield.
  • the reaction can be carried out under various reaction conditions in which the acid is removed by the removal of the t-butyldimethylsilyl group or the trimethylsilyl group. After the completion of the reaction, various methods can be used for the post treatment.
  • the acid used for removing tert-butyldimethylsilyl or trimethylsilyl protection includes hydrochloric acid (HC1), sulfuric acid (H 2 S0 4 ), methanesulfonic acid (MeS0 3 H), benzenesulfonate. Acid (PhS0 3 H) and trifluoroacetic acid, preferably hydrochloric acid.
  • the concentration of the hydrochloric acid for protecting the tert-butyldimethylsilyl or trimethylsilyl group is 0.5-4 mol/L, preferably 1.0 to 2.0 mol/L.
  • the reaction of the step 2 is carried out in a solvent selected from the group consisting of a mixed solvent of acetonitrile-water, methanol-water, acetone-water, tetrahydrofuran-water, etc., wherein the volume concentration of the organic solvent ranges from 40% to ⁇ 80%, preferably an acetonitrile-water solution having a volume concentration of 40% to 80% acetonitrile is used as a reaction solvent.
  • the amount of the solvent used is 4 to 15 mL/g, preferably 6 to 10 mL/g, based on the compound of the formula (XVI).
  • the suitable temperature for the step 2 reaction is 0 to 30 ° C, preferably 15 to 20 ° C.
  • the preparation method provided by the present invention has obvious advantages.
  • the reaction step is greatly shortened, and it is required to prepare a compound represented by the chemical formula ⁇ ) from the compound represented by the chemical formula ⁇ )
  • the preparation method used in the present invention requires only 2 steps, so the reaction cycle is greatly shortened, labor costs are saved, equipment investment for commercial production is reduced, and the types and amounts of solvents used are reduced. The pollution is also relatively reduced, while saving the production costs of the factory.
  • the preparation method of the present invention is easily obtained as a raw material, and the selectivity and yield of the obtained product are remarkably improved as compared with the prior art. detailed description
  • the compound of formula (Ilia) (188 g) was dissolved in dichloromethane (1500 mL), cooled to -40 ° C, and titanium tetrachloride (104 g) in dichloromethane (300 mL) was slowly added. The resulting yellow slurry was stirred for a further 30 minutes. Triethylamine (105 g) was slowly added, then the reaction mixture was warmed to -20 ° C and stirring was continued for 1 hour, then a solution of 4AA (150 g) in dichloromethane (300 mL) was slowly added. After stirring at -20 °C for 3 hours, the reaction was warmed to 5 ° C then quenched with water (750 mL).
  • the compound of formula (XVIa) (51 g) is suspended in acetonitrile with 40% by volume of acetonitrile.
  • Step reaction should be. .
  • the crude crude product of the chemical compound represented by the above-mentioned chemical formula ((XXVVIIIIbb)) is added at about 2200 ° ° CC, toluene benzene ((330000 mm LL) And triethyltriethylamine ((3355..44 gg)), and then post-drip plus p-dodecyldiphenylbenzenesulfonyl-lacide azide nitrogen (227700 ..44 gg)). . After the drop is completed, 5 will return to the room temperature and the reaction should be 55 hours. .
  • the reaction system is concentrated and concentrated to about 220000 ⁇ 330000 mmLL, and then added to the positive gengbeng ((550000 mmLL)), and the ice-cold water bath is cooled by cooling and stirred. Mix about 55 hours. .
  • the filter cake is washed and washed with Zheng Geng Geng, dried and dried to obtain the chemical compound represented by the chemical formula ((nniibb)) ((112266) Gg,, yield yield: 6677%%)), liquid-liquid phase purity purity 9999..44%%. .
  • Methyl 3-oxopentanoate (30 g), toluene (150 mL) and triethylamine (11.6 g) were added at about 15 ° C, then p-dodecylbenzenesulfonyl azide (89.1 g) was added dropwise. After the dropwise addition, the mixture was naturally returned to room temperature for 5 hours. The reaction system was concentrated to a fraction. The crude product was purified by silica gel column chromatography to give the compound of formula (IIIc) (33.8 g, yield 94%), and the liquid phase purity was 98.5%.
  • Titanium tetrachloride (13.2 g) was slowly added at -40 ° C, and the resulting yellow slurry was stirred for further 30 minutes.
  • Triethylamine (14.1 g) was slowly added, then the reaction mixture was warmed to -20 ° C and stirring was continued for 1 hour, then a solution of 4AA (20 g) of dichloromethane (40 mL) was slowly added. After stirring at -20 ° C for 3 hours, The reaction was warmed to rt then EtOAc (EtOAc)EtOAc. The mixture was allowed to stand for separation, the methylene chloride phase was separated, and then concentrated to give a crude product of the formula (XVId).
  • Titanium tetrachloride (13.2 g) was slowly added at -40 ° C, and the resulting yellow slurry was stirred for further 30 minutes.
  • Triethylamine (14.1 g) was slowly added, then the reaction mixture was warmed to -20 ° C and stirring was continued for 1 hour, then a solution of 4AA (20 g) of dichloromethane (40 mL) was slowly added. After stirring at -20 °C for 3 hours, the reaction was warmed to EtOAc EtOAc. The mixture was allowed to stand for separation, and the methylene chloride phase was separated, and then concentrated to give 47.4 g of crude compound of formula (XVI).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a method for preparing a penem antibiotic intermediate. The method comprises the following steps: step 1: preparing an intermediate compound by means of a Mannich reaction; and step 2: converting the intermediate compound into a penem antibiotic intermediate. The method shortens the reaction period, reduces the cost, and reduces environmental pollution, and reaction materials are easily obtained; and the selectivity and the yield of the method are remarkably improved in comparison with the prior art.

Description

一种制备培南类抗生素中间体的方法 技术领域  Method for preparing perennial antibiotic intermediates
本发明涉及药物中间体合成领域,具体涉及一种培南类抗生素中间体 的制备方法。 背景技术  The invention relates to the field of synthesis of pharmaceutical intermediates, in particular to a preparation method of a Pein-like antibiotic intermediate. Background technique
培南类药物如美罗培南、 多尼培南和尔他培南是一类 β-内酰胺类注 射用广谱抗生素。 众所周知, 化学式 (la)所示的化合物是采用铑催化的卡  Pein-type drugs such as meropenem, doripenem and ertapenem are a class of broad-spectrum antibiotics for β-lactam injection. It is well known that the compound represented by the formula (la) is a card catalyzed by ruthenium.
Figure imgf000002_0001
反应式 2所示的合成路线是目前被广泛采用的。 化学式 (la)所示化合 物可以由 β-甲基 -ADC-8 (4-ΒΜΑ, 化学式 (V)所示化合物)经 CDI活化、 亲核加成反应和脱羧反应、脱除 TBS (叔丁基二甲基硅基 Μ呆护和对十二垸 基苯磺酰叠氮参与的重氮化反应方便的制备 0/. Am. Chem. Soc , 1980, 102 6161-6163)。 此路线的难点是带有手性 β-甲基化学式 (V)所示化合物的制 备。
Figure imgf000002_0001
The synthetic route shown in Reaction Scheme 2 is currently widely used. The compound of the formula (la) can be subjected to CDI activation, nucleophilic addition reaction and decarboxylation reaction, and removal of TBS (t-butyl group) by β-methyl-ADC-8 (4-oxime, compound of formula (V)). Dimethylsilyl hydrazine and the diazotization reaction involving t-decylbenzenesulfonyl azide are conveniently prepared. 0. Am. Chem. Soc, 1980, 102 6161-6163). A difficulty with this route is the preparation of a compound represented by the chiral β-methyl formula (V).
Figure imgf000002_0002
4-乙酰基氮杂环丁酮 (4AA, 化学式 (VIII)所示化合物)通常被用于制 备 4-BMA (相关综述: Tetrahedron, 1996, 52, 33 1 -375)。 例如, 由 4AA制 备得到带有末端双键的化学式 (IX)所示化合物,然后通过不对称氢化反应 可以高产率高选择性的制备 4-BMA (US53 10897、US4873324、 EP230792 , 反应式 3)。 然而化学式 (IX)所示化合物制备比较困难。
Figure imgf000002_0002
4-Acetylazetidinone (4AA, a compound of formula (VIII)) is generally used to prepare 4-BMA (reviewed in detail: Tetrahedron, 1996, 52, 33 1 -375). For example, a compound of the formula (IX) having a terminal double bond is prepared from 4AA, and then 4-BMA (US53 10897, US4873324, EP230792, reaction formula 3) can be produced in a high yield and high selectivity by an asymmetric hydrogenation reaction. However, the preparation of the compound of the formula (IX) is difficult.
Figure imgf000003_0001
Figure imgf000003_0001
反应式 3 另一条通过 4AA 制备 4-BMA 的途径是采用辅基诱导的不对称 Reformatsky 反应。 有多种辅基均报道有很好的 β-选择性 (US4791207、 US5104984、 EP197432 , JP06065195)。 然而合成和脱除辅基需要额外的 步骤, 导致成本上升。  Reaction Scheme 3 Another route for the preparation of 4-BMA by 4AA is the use of a pro-radical-induced asymmetric Reformatsky reaction. A variety of prosthetic groups have been reported to have good β-selectivity (US4791207, US5104984, EP197432, JP06065195). However, the synthesis and removal of the prosthetic group requires additional steps, resulting in increased costs.
Figure imgf000003_0002
Figure imgf000003_0002
XI XII XIII  XI XII XIII
反应式 4 还有一种方法是由默克公司开发的
Figure imgf000003_0003
Lett. 1994, 35, 2275-2278)。化学式 (XIV)所示化合物可以由 4AA通过甲基丙二 酸亚异丙酯的偶联反应、 N-硅基化和甲基丙二酸亚异丙酯的溶剂解等一 系列反应得到。 然后经过酸催化的不对称水解和脱除保护基可以以>10: 1 的 β-选择性得到 4-ΒΜΑ。
Another method is developed by Merck.
Figure imgf000003_0003
Lett. 1994, 35, 2275-2278). The compound of the formula (XIV) can be obtained by a series of reactions of 4AA by a coupling reaction of isopropylidene methylmalonate, N-silylation and solvolysis of methyl isopropylidene malonate. The acid-catalyzed asymmetric hydrolysis and removal of the protecting group can then give 4-indole at a β-selectivity of >10:1.
Figure imgf000003_0004
Figure imgf000003_0004
反应式 5 百时美施贵宝公司报道过一系列由 4AA通过直接 Mannich反应制备 化学式(I)所示化合物或其类似物的路线
Figure imgf000004_0001
Letters, 1987, 28, 507-510; Tetrahedron Letters, 1988, 29, 61 -64; Can. J. Chem. 1988, 6, 1400-1404)。 然而这些反应均得到很低的 β-选择性或者很低的产率。
Reaction Formula 5 Bristol-Myers Squibb reported a series of preparations prepared by direct Mannich reaction from 4AA. Route of a compound of formula (I) or an analogue thereof
Figure imgf000004_0001
Letters, 1987, 28, 507-510; Tetrahedron Letters, 1988, 29, 61-64; Can. J. Chem. 1988, 6, 1400-1404). However, these reactions all result in very low β-selectivity or very low yield.
Figure imgf000004_0002
Figure imgf000004_0002
ZnCI2: 78:22 β选择性, 75%收率 ZnCI 2 : 78:22 β selectivity, 75% yield
MgCI2: 60:40 β选择性, 26%收率
Figure imgf000004_0003
MgCI 2 : 60:40 β selectivity, 26% yield
Figure imgf000004_0003
4ΑΑ 4 5  4ΑΑ 4 5
SnCI2: 69:31 β选择性, 70%收率 SnCI 2 : 69:31 β selectivity, 70% yield
TMSOTf: 57:43 β选择性, 75% 收率  TMSOTf: 57:43 β selectivity, 75% yield
MgBr2: 83:17 β 选择性, 8%收率 反应式 6 在持续的开发制备化学式 (IVa)所示化合物及其类似化合物新路线的 过程中,本发明发明人找到一条不仅具有商业价值的,而且具有较短合成 步骤和简单化学的合成路线。本发明的技术内容未见于以往的报道和工作 中。 发明内容 MgBr 2 : 83:17 β selectivity, 8% yield reaction formula 6 In the course of continuous development of a new route for the preparation of the compound of the formula (IVa) and its analogous compounds, the inventors of the present invention found a commercial value. And a synthetic route with shorter synthesis steps and simple chemistry. The technical content of the present invention is not found in previous reports and work. Summary of the invention
本发明的主要目的是提供一条由化学式 (II)所示化合物通过两步反应 制备化学式 所示化合物的简单而且具有商业价值的合成路线。  SUMMARY OF THE INVENTION A primary object of the present invention is to provide a simple and commercially valuable synthetic route for the preparation of a compound of the formula by a two-step reaction of a compound of formula (II).
本发明的另一个目的是提供一条高 β-选择性的采用化学式 σιι)所示 化合物对化学式 (II)所示化合物的直接 Mannich加成反应的方法。  Another object of the present invention is to provide a high β-selective method for direct Mannich addition of a compound of the formula (II) using a compound of the formula σιι).
另外, 本发明还提供了该 Mannich反应的最佳反应条件。 本发明提供了一条制备化学式 σ)所示的培南类抗生素中间体的方 法, 由反应式 7中所示的步骤构成。 In addition, the present invention also provides optimum reaction conditions for the Mannich reaction. The present invention provides a process for preparing a penicillin antibiotic intermediate represented by the chemical formula σ), which comprises the steps shown in Reaction Scheme 7.
Figure imgf000005_0001
本发明中, 化学式 σ)所示化合物简称为化合物 σ), 其他化合物也采 用相应的简称。
Figure imgf000005_0001
In the present invention, the compound represented by the chemical formula σ) is abbreviated as the compound σ), and the other compounds are also referred to as corresponding abbreviations.
本发明中, 下列物质用其相应的简称代替:  In the present invention, the following substances are replaced by their corresponding abbreviations:
TMS: 三甲基硅基;  TMS: trimethylsilyl;
TBS: 叔丁基二甲基硅基;  TBS: tert-butyldimethylsilyl;
ΡΝΒ : 对硝基苄基;  ΡΝΒ : p-nitrobenzyl;
Me: 甲基;  Me: methyl;
Et: 乙基;  Et: ethyl;
Bz: 苯甲酰基;  Bz: benzoyl;
Ac: 乙酰基;  Ac: acetyl group;
Bn: 苄基;  Bn: benzyl;
Allyl: 烯丙基。  Allyl: allyl.
在反应式 7中, R1代表的官能团包括但不限于: 甲基 (Me)、 乙基 (Et)、 对硝基苄基 (PNB)、 苄基 (Bn)、 烯丙基 (Allyl)、 4-氯苄基、 2-硝基苄基、 3- 硝基苄基、 4-甲氧基苄基; In Reaction Scheme 7, the functional group represented by R 1 includes, but is not limited to, methyl (Me), ethyl (Et), p-nitrobenzyl (PNB), benzyl (Bn), allyl (Allyl), 4-chlorobenzyl, 2-nitrobenzyl, 3-nitrobenzyl, 4-methoxybenzyl;
R2代表的官能团包括但不限于: 乙酰基 (Ac)、 苯甲酰基 (Bz); The functional group represented by R 2 includes, but is not limited to, acetyl (Ac), benzoyl (Bz);
R2代表的官能团包括但不限于: 三甲基硅基 (TMS)、 叔丁基二甲基硅 基 (TBS)。 The functional groups represented by R 2 include, but are not limited to, trimethylsilyl (TMS), tert-butyldimethylsilyl (TBS).
化学式 (III)所示化合物可通过现有方法简便合成得到。  The compound of the formula (III) can be easily synthesized by a conventional method.
反应式 7中的内容实质上包含两个步骤:  The content in Equation 7 consists essentially of two steps:
步骤 h 化学式 (Π)所示化合物与化学式 σιι)所示化合物反应得到化 学式 (XVI)所示化合物;  Step h The compound of the formula (Π) is reacted with a compound of the formula σιι) to obtain a compound of the formula (XVI);
步骤 2 : 由化学式 (XVI)所示化合物制备化学式 所示化合物, 即 β- 甲基培南类抗生素中间体。 Step 2: The compound represented by the chemical formula (XVI) is prepared, that is, β- Methylpenic antibiotic intermediate.
其中步骤 1和步骤 2根据如下反应条件进行:  Steps 1 and 2 are carried out according to the following reaction conditions:
对于步骤 1, 反应可以在多种已知的路易斯 (Lewis) 酸催化的直接 曼奇尼 (Mannich) 反应的条件下进行。 反应完成后, 可采用多种方法进 行后处理。  For step 1, the reaction can be carried out under a variety of known Lewis acid catalyzed direct Mannich reactions. After the reaction is completed, various methods can be used for post treatment.
所述用于 Mannich反应的 Lewis酸可以为现有用于 Mannich反应的 任意种酸, 包括但不限于四氯化钛 (TiCl4)、 四溴化钛 (TiBr4)、 四氯化硅 (SiCl4)、三氯化镧 (LaCl3)、氯化锌 (ZnCl2)、溴化锌 (ZnBr2)、氯化镁 (MgCl2)、 三溴化硼 (BBr3)、 氯化铜 (CuCl2)、 三氟甲磺酸铜 (Cu(OTf)2)、 三氟甲磺酸 亚铜 (CuOTf)、 碘化亚铜 (Cul)、 三氯化硼 (BC13)等, 优选采用相对较便宜 的四氯化钛 (TiCl4)。 The Lewis acid used in the Mannich reaction may be any of the existing acids used in the Mannich reaction, including but not limited to titanium tetrachloride (TiCl 4 ), titanium tetrabromide (TiBr 4 ), silicon tetrachloride (SiCl 4 ). ), lanthanum trichloride (LaCl 3 ), zinc chloride (ZnCl 2 ), zinc bromide (ZnBr 2 ), magnesium chloride (MgCl 2 ), boron tribromide (BBr 3 ), copper chloride (CuCl 2 ), Copper triflate (Cu(OTf) 2 ), cuprous triflate (CuOTf), cuprous iodide (Cul), boron trichloride (BC1 3 ), etc., preferably using relatively inexpensive four Titanium chloride (TiCl 4 ).
Lewis 酸与化学式 (II)所示化合物的摩尔比为 0.8~3.0 : 1, 优选为 1.0-1.5: l o 如果采用较少的 Lewis酸, 反应无法进行完全。  The molar ratio of the Lewis acid to the compound of the formula (II) is 0.8 to 3.0:1, preferably 1.0 to 1.5: l o If less Lewis acid is used, the reaction cannot be completed.
步骤 1的反应中还存在路易斯 (Lewis) 碱。 所述 Lewis碱可以为现 有用于 Mannich反应的任意种碱, 包括但不限于三乙胺、 二异丙基乙胺、 三正丁胺、 四甲基乙二胺、 4-甲基吗啉、 1,8-二氮杂双环 [5.4.0]十一碳 -7- 烯、 1,4-二氮杂二环 [2.2.2]辛垸、 4-二甲胺基吡啶、 N-甲基吡咯垸、 N-甲 基哌啶、 二乙胺、 二异丙胺、 吡咯、 哌啶、 六甲基磷酰三胺、 吡啶、 3- 甲基吡啶及它们的组合。 优选采用其中的三级胺。  A Lewis base is also present in the reaction of step 1. The Lewis base may be any of the bases currently used in the Mannich reaction, including but not limited to triethylamine, diisopropylethylamine, tri-n-butylamine, tetramethylethylenediamine, 4-methylmorpholine, 1,8-diazabicyclo[5.4.0]undec-7-ene, 1,4-diazabicyclo[2.2.2]octane, 4-dimethylaminopyridine, N-methyl Pyrrolizine, N-methylpiperidine, diethylamine, diisopropylamine, pyrrole, piperidine, hexamethylphosphoric triamide, pyridine, 3-methylpyridine, and combinations thereof. It is preferred to use a tertiary amine therein.
Lewis 碱与化学式 (II)所示化合物的摩尔比为 1.2~4.0 : 1, 优选为 The molar ratio of the Lewis base to the compound of the formula (II) is from 1.2 to 4.0:1, preferably
1.8-2.5: 1。 1.8-2.5: 1.
作为优选的技术方案, 步骤 1的反应通常为: 将化学式 所示化合 物溶解于有机溶剂中, 冷却, 然后加入 Lewis酸及 Lewis碱, 搅拌, 加入 化学式 (Π)所示化合物, 然后反应直至终点。  As a preferred technical solution, the reaction of the step 1 is usually carried out by dissolving the compound of the formula in an organic solvent, cooling, then adding a Lewis acid and a Lewis base, stirring, adding a compound of the formula (Π), and then reacting until the end.
所述溶剂包括二氯甲垸、 1,2-二氯乙垸、 甲苯、 乙腈、 四氢呋喃、 甲 基叔丁基醚、 2-甲基四氢呋喃或它们的组合。 优选采用二氯甲垸、 1,2-二 氯乙垸或它们的组合。  The solvent includes methylene chloride, 1,2-dichloroacetonitrile, toluene, acetonitrile, tetrahydrofuran, methyl t-butyl ether, 2-methyltetrahydrofuran or a combination thereof. Preferably, methylene chloride, 1,2-dichloroethane or a combination thereof is used.
所述溶剂的用量相对于化学式 (Π)所示化合物用量为 8~30 mL/g (即 每克化学式 (Π)所示化合物使用溶剂 8~30 mL) , 优选为 12~20 mL/g。  The solvent is used in an amount of 8 to 30 mL/g based on the compound of the formula (Π) (i.e., 8 to 30 mL of the solvent per gram of the compound represented by the formula (Π), preferably 12 to 20 mL/g.
化学式 (III)所示化合物与化学式 (Π)所示化合物的摩尔比为 1.0~2.0 : 1, 优选为 1.2~1.5: 1。 The molar ratio of the compound of the formula (III) to the compound of the formula (Π) is 1.0 to 2.0: 1, preferably 1.2 to 1.5: 1.
步骤 1的反应温度为 -60~10°C, 优选 -30~0°C。  The reaction temperature in the step 1 is -60 to 10 ° C, preferably -30 to 0 ° C.
具体来说, 所述 Lewis酸及 Lewis碱加入的合适温度为 -60~0°C, 优 选为 -50— 30°C。 化学式 (II)所示化合物加入前合适的搅拌时间应该为 10~60分钟, 优选 20~30分钟。 化学式 (II)所示化合物加入的合适温度为 -60~0°C, 优选 -40〜- 20°C。 反应的合适温度为 -40~10°C, 优选 -20~0°C。 反 应在较低的温度下将会进行的非常缓慢。 合适的反应时间应该在 4 小时 内, 如果可能, 反应应该在 2.5小时内完成。 较长的反应时间会导致生成 更多的杂质并降低产率。  Specifically, a suitable temperature for the addition of the Lewis acid and the Lewis base is -60 to 0 ° C, preferably -50 to 30 ° C. The appropriate stirring time before the addition of the compound of the formula (II) should be 10 to 60 minutes, preferably 20 to 30 minutes. A suitable temperature for the addition of the compound of the formula (II) is -60 to 0 ° C, preferably -40 to 20 ° C. A suitable temperature for the reaction is -40 to 10 ° C, preferably -20 to 0 ° C. The reaction will proceed very slowly at lower temperatures. The appropriate reaction time should be within 4 hours and, if possible, the reaction should be completed within 2.5 hours. Longer reaction times result in more impurities and lower yields.
反应完成后, 采用水溶液如氯化钠水溶液、 碳酸氢钠水溶液、 磷酸二 氢钠水溶液、磷酸二氢钾水溶液、 氯化镁水溶液、 氯化钙水溶液或纯水淬 灭反应, 优选采用纯水。 其中, 所述水溶液的浓度为常用的淬灭溶液的浓 度, 优选溶质的质量百分比可以为 5% ~ 25%。  After completion of the reaction, the reaction is quenched with an aqueous solution such as aqueous sodium chloride solution, aqueous sodium hydrogencarbonate solution, aqueous sodium dihydrogen phosphate solution, aqueous potassium dihydrogen phosphate solution, aqueous magnesium chloride solution, aqueous calcium chloride solution or purified water, preferably using pure water. Wherein, the concentration of the aqueous solution is a concentration of a common quenching solution, and preferably the mass percentage of the solute may be 5% to 25%.
淬灭溶液的用量相对于化学式 (Π)所示化合物用量为 3~30 mL/g, 优 选为 5~10 mL/g。  The amount of the quenching solution is 3 to 30 mL/g, preferably 5 to 10 mL/g, based on the compound of the formula (Π).
步骤 1所得的化学式 (XVI)所示化合物产品可以直接将粗品用于下一 步反应, 也可进一步纯化后使用, 优选采用甲醇、 甲醇 -水、 乙醇、 乙醇- 水、 丙酮、 丙酮 -水、 乙腈、 异丙醇、 正己垸、 正庚垸、 甲苯、 石油醚等 溶剂通过重结晶纯化, 更优选采用甲醇-水进行重结晶纯化。 重结晶溶剂 的用量相对于化学式 (II)所示化合物用量为 3~20 mL/g,优选为 4~8 mL/g。 采用较多的溶剂会降低产率。  The compound of the formula (XVI) obtained in the step 1 can be directly used for the next reaction, or can be further purified, preferably using methanol, methanol-water, ethanol, ethanol-water, acetone, acetone-water, acetonitrile. Solvents such as isopropanol, n-hexanol, n-glycol, toluene, petroleum ether, etc. are purified by recrystallization, more preferably by recrystallization from methanol-water. The amount of the recrystallization solvent is from 3 to 20 mL/g, preferably from 4 to 8 mL/g, based on the compound of the formula (II). Using more solvent will reduce the yield.
对于步骤 2, 反应可以在多种采用酸脱除叔丁基二甲基硅基或三甲基 硅基保护的反应条件下进行, 反应完成后, 可采用多种方法进行后处理。  For the step 2, the reaction can be carried out under various reaction conditions in which the acid is removed by the removal of the t-butyldimethylsilyl group or the trimethylsilyl group. After the completion of the reaction, various methods can be used for the post treatment.
所述的用于脱除叔丁基二甲基硅基或三甲基硅基保护的酸包括盐酸 (HC1)、 硫酸 (H2S04)、 甲基磺酸 (MeS03H)、 苯磺酸 (PhS03H)和三氟乙酸, 优选采用盐酸。 The acid used for removing tert-butyldimethylsilyl or trimethylsilyl protection includes hydrochloric acid (HC1), sulfuric acid (H 2 S0 4 ), methanesulfonic acid (MeS0 3 H), benzenesulfonate. Acid (PhS0 3 H) and trifluoroacetic acid, preferably hydrochloric acid.
所述用于脱除叔丁基二甲基硅基或三甲基硅基保护的盐酸的浓度为 0.5-4 mol/L, 优选为 1.0~2.0 mol/L。  The concentration of the hydrochloric acid for protecting the tert-butyldimethylsilyl or trimethylsilyl group is 0.5-4 mol/L, preferably 1.0 to 2.0 mol/L.
步骤 2的反应在溶剂中进行, 所述溶剂选自乙腈 -水、 甲醇 -水、 丙酮 -水、 四氢呋喃 -水等的混合溶剂, 其中有机溶剂的体积浓度范围为 40% ~ 80%, 优选采用体积浓度为 40% 〜 80%乙腈含量的乙腈-水溶液作为反应 溶剂。 溶剂的用量相对于为化学式 (XVI)所示化合物用量为 4~15 mL/g, 优选为 6~10 mL/g。 The reaction of the step 2 is carried out in a solvent selected from the group consisting of a mixed solvent of acetonitrile-water, methanol-water, acetone-water, tetrahydrofuran-water, etc., wherein the volume concentration of the organic solvent ranges from 40% to ~ 80%, preferably an acetonitrile-water solution having a volume concentration of 40% to 80% acetonitrile is used as a reaction solvent. The amount of the solvent used is 4 to 15 mL/g, preferably 6 to 10 mL/g, based on the compound of the formula (XVI).
步骤 2反应合适的温度为 0~30°C, 优选为 15~20°C。  The suitable temperature for the step 2 reaction is 0 to 30 ° C, preferably 15 to 20 ° C.
与以往的路线相比, 本发明提供的制备方法有明显的优势。反应步骤 大大縮短, 与以往从化学式 σι)所示化合物制备化学式 σ)所示化合物需要 Compared with the prior route, the preparation method provided by the present invention has obvious advantages. The reaction step is greatly shortened, and it is required to prepare a compound represented by the chemical formula σ) from the compound represented by the chemical formula σι)
5~7步相比, 本发明中所用的制备方法只需要 2步, 因此反应周期大大縮 短, 节约了人工成本, 用于商业化生产的设备投资减少, 所用溶剂的种类 及用量减少, 对环境的污染也相对减轻, 同时节约了工厂的生产成本。 本 发明的制备方法反应原料易得,所得产物的选择性和收率相对于现有方法 都有明显提高。 具体实施方式 Compared with the 5~7 steps, the preparation method used in the present invention requires only 2 steps, so the reaction cycle is greatly shortened, labor costs are saved, equipment investment for commercial production is reduced, and the types and amounts of solvents used are reduced. The pollution is also relatively reduced, while saving the production costs of the factory. The preparation method of the present invention is easily obtained as a raw material, and the selectivity and yield of the obtained product are remarkably improved as compared with the prior art. detailed description
以下实施例用于说明本发明,但不用来限制本发明的范围。若未特别 指明, 实施例中所用的试剂均为常规市售试剂, 实施例中所用的技术手段 为本领域技术人员所熟知的常规手段。  The following examples are intended to illustrate the invention but are not intended to limit the scope of the invention. Unless otherwise specified, the reagents used in the examples are conventional commercially available reagents, and the technical means used in the examples are conventional means well known to those skilled in the art.
实施例 1 Example 1
( 1 ) 制备化学式 (XVIa)所示化合物  (1) Preparation of a compound of the formula (XVIa)
Figure imgf000008_0001
化合物 (Ilia)参考文献 US 4644061A1 ( 1987 ) 合成。
Figure imgf000008_0001
Compound (Ilia) is synthesized by reference to US 4644061 A1 (1987).
化学式 (Ilia)所示化合物(188 g)溶解于二氯甲垸(1500 mL)中, 冷却至 -40°C, 缓慢加入四氯化钛 (104 g)的二氯甲垸 (300 mL)溶液, 所得的黄色 浆状物继续搅拌 30分钟。缓慢加入三乙胺 (105 g), 然后反应液升至 -20°C 并继续搅拌 1小时, 然后缓慢加入 4AA (150 g)的二氯甲垸 (300 mL)溶液。 在 -20°C下搅拌 3小时后, 将反应物升温至 5°C, 然后用水 (750 mL)淬灭。 静置分层, 分出二氯甲垸相, 滤过一层硅胶 (75 g), 然后浓縮。 HPLC表 明反应体系中产物的 β/α 比为 8.8: 1。 剩余物用甲醇 (300 mL)洗料, 过滤 得化学式 (XVIa)所示化合物, 液相纯度为 80%, β/α 比为 30:1, 直接用于 下一步反应。 The compound of formula (Ilia) (188 g) was dissolved in dichloromethane (1500 mL), cooled to -40 ° C, and titanium tetrachloride (104 g) in dichloromethane (300 mL) was slowly added. The resulting yellow slurry was stirred for a further 30 minutes. Triethylamine (105 g) was slowly added, then the reaction mixture was warmed to -20 ° C and stirring was continued for 1 hour, then a solution of 4AA (150 g) in dichloromethane (300 mL) was slowly added. After stirring at -20 °C for 3 hours, the reaction was warmed to 5 ° C then quenched with water (750 mL). The layers were allowed to stand, the methylene chloride phase was separated, and a layer of silica gel (75 g) was filtered and concentrated. HPLC showed the product in the reaction system to have a β/α ratio of 8.8:1. The residue was washed with methanol (300 mL), filtered The compound of the formula (XVIa) has a liquid phase purity of 80% and a β/α ratio of 30:1, which is directly used in the next reaction.
Ή NMR (400 MHz, CDC13): δ 8.22 (d, J= 8.7 Hz, 2H), 7.51 (d, J= 8.6 Hz, 2H), 6.10 (s, IH), 5.33 (s, 2H), 4.18-4.12 (m, IH), 3.92-3.86 (m, 2H), 2.94 (d,J=4.3 Hz, IH), 1.17-1.15 (m, 6H), 0.83 (s, 9H), 0.04 (d, J= 5.2 Hz, 6H)。 NMR NMR (400 MHz, CDC1 3 ): δ 8.22 (d, J = 8.7 Hz, 2H), 7.51 (d, J = 8.6 Hz, 2H), 6.10 (s, IH), 5.33 (s, 2H), 4.18 -4.12 (m, IH), 3.92-3.86 (m, 2H), 2.94 (d, J=4.3 Hz, IH), 1.17-1.15 (m, 6H), 0.83 (s, 9H), 0.04 (d, J = 5.2 Hz, 6H).
(2) 制备化学式 (la)所示化合物  (2) Preparation of a compound of the formula (la)
Figure imgf000009_0001
化学式 (XVIa)所示化合物 (51 g)悬浮于乙腈体积百分比为 40%的乙腈
Figure imgf000009_0001
The compound of formula (XVIa) (51 g) is suspended in acetonitrile with 40% by volume of acetonitrile.
-水溶液 (300 mL)中,在 15~20°C下加入 1NHC1(100 mL)。反应在 15~20 °C 下搅拌直至反应完全。 加入 300 mL乙酸乙酯, 用饱和碳酸氢钠调节水相 的 pH到 6~7。 静置分出有机相, 用 150 mL饱和食盐水洗涤, 浓縮, 加 入 150 mL甲苯析晶, 过滤得到化学式 (la)所示化合物 (36 g,产率 92.3%), 液相纯度>97%。 In an aqueous solution (300 mL), 1NHC1 (100 mL) was added at 15 to 20 °C. The reaction was stirred at 15 to 20 ° C until the reaction was complete. Add 300 mL of ethyl acetate and adjust the pH of the aqueous phase to 6-7 with saturated sodium bicarbonate. The organic phase was separated, washed with 150 mL of brine, concentrated, 150 mL of toluene, and filtered to give the compound of formula (la) (36 g, yield 92.3%), liquid phase purity >97% .
lR NMR (400 MHz, CDC13): δ 8.25 (d, J= 8.7 Hz, 2H), 7.53 (d, J= 8.7lR NMR (400 MHz, CDC1 3 ): δ 8.25 (d, J = 8.7 Hz, 2H), 7.53 (d, J = 8.7
Hz, 2H), 6.25 (br, IH), 5.35 (s, 2H), 4.13-4.17 (m, IH), 3.88 (dd, J= 8.5, 2.0Hz, 2H), 6.25 (br, IH), 5.35 (s, 2H), 4.13-4.17 (m, IH), 3.88 (dd, J= 8.5, 2.0
Hz, IH), 3.62 (dd, J= 8.3, 7.2 Hz, IH), 2.96 (d, J= 4.5 Hz, IH), 2.89 (dd, JHz, IH), 3.62 (dd, J= 8.3, 7.2 Hz, IH), 2.96 (d, J= 4.5 Hz, IH), 2.89 (dd, J
= 6.0, 2.0 Hz, IH), 1.30 (d, J = 8.4 Hz, 3H), 1.20 (d, J= 8.4 Hz, 3H)。 = 6.0, 2.0 Hz, IH), 1.30 (d, J = 8.4 Hz, 3H), 1.20 (d, J = 8.4 Hz, 3H).
实施例 2 Example 2
(1) 制备化学式 (nib)所示化合物 (1) Preparation of a compound of the formula (nib)
Figure imgf000009_0002
在约 20 °C下加入对氯苄醇 (100 g), 3-氧代戊酸甲酯 (100 g)和甲苯
Figure imgf000009_0002
Add p-chlorobenzyl alcohol (100 g), methyl 3-oxopentanoate (100 g) and toluene at about 20 °C
(300 mL), 加热至回流, 采用常压蒸馏装置蒸出溶剂至体系温度升至 150 °°CC。。 重重复复 33~~44次次,, 所所得得化化学学式式 ((XXVVIIIIbb))所所示示化化合合物物的的粗粗品品直直接接用用于于下下一一步步 反反应应。。 (300 mL), heated to reflux, and the solvent was distilled off using an atmospheric distillation apparatus until the temperature of the system rose to 150. ° ° CC. . Repeatingly repeating 33~~44 times, the obtained crude chemical product of the chemical compound formula ((XXVVIIIIbb)) is directly used for the next step. Step reaction should be. .
在在约约 2200 °°CC下下加加入入上上述述化化学学式式 ((XXVVIIIIbb))所所示示化化合合物物的的粗粗品品,, 甲甲苯苯 ((330000 mmLL))和和三三乙乙胺胺 ((3355..44 gg)),, 然然后后滴滴加加对对十十二二垸垸基基苯苯磺磺酰酰叠叠氮氮 ((227700..44 gg))。。 滴滴毕毕,, 5 自自然然恢恢复复到到室室温温反反应应 55小小时时。。 反反应应体体系系浓浓縮縮至至约约 220000~~330000 mmLL,, 然然后后加加入入 正正庚庚垸垸 ((550000 mmLL)),, 冰冰水水浴浴冷冷却却搅搅拌拌约约 55小小时时。。 过过滤滤,, 滤滤饼饼用用正正庚庚垸垸洗洗涤涤,, 干干燥燥得得到到化化学学式式 ((nniibb))所所示示化化合合物物((112266 gg,, 产产率率 6677%%)),, 液液相相纯纯度度 9999..44%%。。  The crude crude product of the chemical compound represented by the above-mentioned chemical formula ((XXVVIIIIbb)) is added at about 2200 ° ° CC, toluene benzene ((330000 mm LL) And triethyltriethylamine ((3355..44 gg)), and then post-drip plus p-dodecyldiphenylbenzenesulfonyl-lacide azide nitrogen (227700 ..44 gg)). . After the drop is completed, 5 will return to the room temperature and the reaction should be 55 hours. . The reaction system is concentrated and concentrated to about 220000~~330000 mmLL, and then added to the positive gengbeng ((550000 mmLL)), and the ice-cold water bath is cooled by cooling and stirred. Mix about 55 hours. . After filtering through the filter, the filter cake is washed and washed with Zheng Geng Geng, dried and dried to obtain the chemical compound represented by the chemical formula ((nniibb)) ((112266) Gg,, yield yield: 6677%%)), liquid-liquid phase purity purity 9999..44%%. .
llRR NNMMRR ((440000 MMHHzz,, CCDDCC1133)):: δδ 77..3366 ((dd,, JJ == 88..55 HHzz,, 22HH)),, 77..3300 ((dd,, JJ == 88..55 HHzz,, 22HH)),, 55..2222 ((ss,, 22HH)),, 22..8866 ((qq,, JJ == 77..33 HHzz,, 22HH)),, 11..1144 ((tt,, JJ == 77..33 HHzz,, 33HH))。。 l l RR NNMMRR ((440000 MMHHzz,, CCDDCC11 33 )):: δδ 77..3366 ((dd,, JJ == 88..55 HHzz,, 22HH)),, 77..3300 ((dd,, JJ == 88..55 HHzz,, 22HH)),, 55..2222 ((ss,, 22HH)),, 22..8866 ((qq,, JJ == 77..33 HHzz,, 22HH) ),, 11..1144 ((tt,, JJ == 77..33 HHzz,, 33HH)). .
Figure imgf000010_0001
Figure imgf000010_0001
化化学学式式 ((IIllllbb))所所示示化化合合物物 ((2255 溶溶解解于于二二氯氯甲甲垸垸 ((228800 mmLL))中中,, 冷冷却却至至 1155 --4400°°CC,, 缓缓慢慢加加入入四四氯氯化化钛钛 ((1133..22 gg)),, 所所得得的的黄黄色色浆浆状状物物继继续续搅搅拌拌 3300分分钟钟。。 Chemical compound formula ((IIllllbb)) shown in the chemical compound ((2255 dissolved in dichlorochloromethylformamidine ((228800 mmLL)), cold cooling to 1155 --4400 ° ° CC,, slowly and slowly added to the titanium tetrachloride titanium chloride ((1133..22 gg)), the obtained yellow-yellow color slurry Continue to stir and stir for 3,300 minutes.
缓缓慢慢加加入入三三乙乙胺胺 ((1144..11 gg)) ,, 然然后后反反应应液液升升至至 --2200°°CC并并继继续续搅搅拌拌 11小小时时,, 然然后后 缓缓慢慢加加入入 44AAAA ((2200 gg))的的二二氯氯甲甲垸垸 ((4400 mmLL))溶溶液液。。 在在 --2200°°CC下下搅搅拌拌 33小小时时后后,, 将将反反应应物物升升温温至至室室温温,, 然然后后用用水水 ((115500 mmLL))淬淬灭灭。。 静静置置分分层层,, 分分出出二二氯氯甲甲垸垸 相相,,然然后后浓浓縮縮。。剩剩余余物物用用硅硅胶胶柱柱色色谱谱纯纯化化得得化化学学式式 ((XXVVIIbb))所所示示化化合合物物 ((1177..00 2200 gg,, 4499%% 产产率率)),, ββ//αα 比比为为 77..33 :: 11。。  Slowly and slowly add tributyl triethylamine ((1144..11 gg)), and then the reaction should be raised to -2200 ° ° CC and continue to stir and stir. At 11 hours, then slowly and slowly add 44AAAA ((2200 gg)) of dichlorochloromethane ((4400 mmLL)) solution. . After stirring for 33 hours at -2200 ° ° CC, the reaction product will be warmed to room temperature, and then water ((115500 mm LL)) Quenching and extinction. . The layer was layered quietly, and the phase of dichlorochloromethane was separated out, and then concentrated and concentrated. . The remaining residue was purified by column chromatography using silica gel column chromatography to obtain the chemical compound represented by the chemical formula ((XXVVIIbb)) ((1177..00 2200 gg, 4499) %% yield rate)), ββ//αα ratio is 77..33::11. .
! !HH NNMMRR (( ββ异异构构体体)) ((440000 MMHHzz,, CCDDCC1133)):: δδ 77..3355 ((άά,, JJ == 88..55 HHzz,, 22ΗΗ)),, 77..3300 ((dd,, JJ == 88..44 HHzz,, 22HH)),, 55..9922 ((ss,, 11HH)),, 55..2211 ((dd,, JJ == 22..11HHzz,, 22HH)),, 44..1199--44..1144 ((mm,, 11HH)),, 33..9922--33..8877 ((mm,, 22HH)),, 22..9955 ((dddd,, JJ == 44..00,, 11..88 HHzz,, 11HH)),, 11..1188--11..1155 ((mm,, 66HH)),, 00..8844 ((ss,, 99HH)),, 00..0044 ((dd,, JJ == 66..00 HHzz,, 66HH))。。 !! HH NNMMRR ((ββ isomer thereof iso isomers)) ((440000 MMHHzz ,, CCDDCC11 33)) :: δδ 77..3355 ((άά ,, JJ == 88..55 HHzz ,, 22ΗΗ)) ,, 77..3300 ((dd,, JJ == 88..44 HHzz,, 22HH)),, 55..9922 ((ss,, 11HH)),, 55..2211 ((dd,, JJ == 22..11HHzz,, 22HH)),, 44..1199--44..1144 ((mm,, 11HH)),, 33..9922--33..8877 ((mm,, 22HH) ),, 22..9955 ((dddd,, JJ == 44..00,, 11..88 HHzz,, 11HH)),, 11..1188--11..1155 ((mm,, 66HH) ),, 00..8844 ((ss,, 99HH)),, 00..0044 ((dd,, JJ == 66..00 HHzz,, 66HH)). .
2255 *
Figure imgf000011_0001
化学式 (XVIb)所示化合物 (15 g)悬浮于乙腈体积百分比为 40%的乙腈 -水溶液(100 mL)中,在 15~20°C下加入 IN HCl (36mL)。反应在 15~20 °C 下搅拌直至反应完全。 加入 120 mL乙酸乙酯, 用饱和碳酸氢钠调节水相 的 pH到 6~7。 静置分出有机相, 用 45 mL饱和食盐水洗涤, 浓縮, 硅胶 柱色谱纯化得到化学式 (lb)所示化合物(11.4 g, 100% 产率), β/α 比为 7.3:1。
2255 *
Figure imgf000011_0001
The compound of the formula (XVIb) (15 g) was suspended in an acetonitrile-water solution (100 mL) of 40% by volume of acetonitrile, and IN HCl (36 mL) was added at 15 to 20 °C. The reaction was stirred at 15 to 20 ° C until the reaction was completed. 120 mL of ethyl acetate was added and the pH of the aqueous phase was adjusted to 6-7 with saturated sodium bicarbonate. The organic phase was separated, washed with 45 mL of brine, concentrated, and purified by silica gel column chromatography to give the compound of formula (lb) (11.4 g, 100% yield) with a ratio of 7.3:1.
!H NMR (β异构体) (400 MHz, CDC13): δ 7.37 (ά, J = 8.4 Hz, 2Η), ! H NMR (β-isomer) (400 MHz, CDC1 3) : δ 7.37 (ά, J = 8.4 Hz, 2Η),
7.29 (d, J= 8.4 Hz, 2H), 6.74 (br, 1H), 5.28 (s, 2H), 4.04-4.09 (m, 1H), 3.80 (dd, J= 6.4, 2.1 Hz, 1H), 3.69-3.75 (m, 1H), 2.85 (dd, J= 6.6, 1.8 Hz, 1H),7.29 (d, J= 8.4 Hz, 2H), 6.74 (br, 1H), 5.28 (s, 2H), 4.04-4.09 (m, 1H), 3.80 (dd, J= 6.4, 2.1 Hz, 1H), 3.69 -3.75 (m, 1H), 2.85 (dd, J= 6.6, 1.8 Hz, 1H),
2.67 (brs, 1H), 1.22 (d, J= 6.3 Hz, 3H), 1.17 (d,J= 6.3 Hz, 3H)。 2.67 (brs, 1H), 1.22 (d, J = 6.3 Hz, 3H), 1.17 (d, J = 6.3 Hz, 3H).
实施例 3 Example 3
(1) 制备化学式 (Hie)所示化合物 (1) Preparation of a compound of the formula (Hie)
Figure imgf000011_0002
在约 15 °C下加入 3-氧代戊酸甲酯 (30 g),甲苯 (150 mL)和三乙胺 (11.6 g), 然后滴加对十二垸基苯磺酰叠氮 (89.1 g 滴毕, 自然恢复到室温反 应 5 小时。 反应体系浓縮至无馏分, 粗品用硅胶柱色谱纯化得到化学式 (IIIc)所示化合物 (33.8 g, 产率 94%), 液相纯度 98.5%。
Figure imgf000011_0002
Methyl 3-oxopentanoate (30 g), toluene (150 mL) and triethylamine (11.6 g) were added at about 15 ° C, then p-dodecylbenzenesulfonyl azide (89.1 g) was added dropwise. After the dropwise addition, the mixture was naturally returned to room temperature for 5 hours. The reaction system was concentrated to a fraction. The crude product was purified by silica gel column chromatography to give the compound of formula (IIIc) (33.8 g, yield 94%), and the liquid phase purity was 98.5%.
1ΊΆ NMR (400 MHz, CDC13): δ 3.83 (s, 3H), 2.86 (q, J = 7.3 Hz, 2H), 1 Ί Ά NMR (400 MHz, CDC1 3): δ 3.83 (s, 3H), 2.86 (q, J = 7.3 Hz, 2H),
1.14 (t,J= 7.3 Hz, 3H 1.14 (t, J = 7.3 Hz, 3H
(2) 制备化学式 (XVIc)所示化合物
Figure imgf000012_0001
化学式 (IIIc)所示化合物(14.1 g)溶解于二氯甲垸 (280 mL)中, 冷却至 -40°C, 缓慢加入四氯化钛 (13.2 g), 所得的黄色浆状物继续搅拌 30分钟。 缓慢加入三乙胺 (14.1 g), 然后反应液升至 -20°C并继续搅拌 1小时, 然后 缓慢加入 4AA (20 g)的二氯甲垸 (40 mL)溶液。 在 -20°C下搅拌 3小时后, 将反应物升温至室温, 然后用水 (150 mL)淬灭。 静置分层, 分出二氯甲垸 相,然后浓縮。剩余物用硅胶柱色谱纯化得化学式 (XVIc)所示化合物 (11.5 g, 43% 产率), β/α 比为 4.2: 1。
(2) Preparation of a compound of the formula (XVIc)
Figure imgf000012_0001
The compound of the formula (IIIc) (14.1 g) was dissolved in dichloromethane (280 mL), cooled to -40 ° C, titanium tetrachloride (13.2 g) was slowly added, and the resulting yellow slurry was stirred continuously. minute. Triethylamine (14.1 g) was slowly added, then the reaction mixture was warmed to -20 ° C and stirring was continued for 1 hour, and then a solution of 4AA (20 g) of dichloromethane (40 mL) was slowly added. After stirring at -20 °C for 3 hours, the reaction was warmed to EtOAc EtOAc. The layers were allowed to stand, the methylene chloride phase was separated, and then concentrated. The residue was purified by silica gel column chromatography toield of compound of formula (XVIc) (11.5 g, 43% yield). The ratio of β/α was 4.2:1.
^ NMR ( β异构体)(400 MHz, CDC13): δ 5.97 (brs, 1Η), 4.17-4.19 (m, 1H), 3.85-3.94 (m, 1H), 3.84 (s, 3H), 2.92 (dd, J = 3.9, 1.8 Hz, 1H), 1.17-1.20 (m, 6H), 0.88 (s, 9H), 0.07 (d, J= 6.0 Hz, 6H)。 ^ NMR (β isomer) (400 MHz, CDC1 3 ): δ 5.97 (brs, 1Η), 4.17-4.19 (m, 1H), 3.85-3.94 (m, 1H), 3.84 (s, 3H), 2.92 (dd, J = 3.9, 1.8 Hz, 1H), 1.17-1.20 (m, 6H), 0.88 (s, 9H), 0.07 (d, J = 6.0 Hz, 6H).
( 3 ) 制备化学式 (Ic)所示化合物  (3) Preparation of a compound of the formula (Ic)
Figure imgf000012_0002
化学式 (XVIa)所示化合物 (10 g)悬浮于乙腈体积百分比为 40%的乙腈
Figure imgf000012_0002
The compound of formula (XVIa) (10 g) was suspended in acetonitrile with 40% by volume of acetonitrile.
-水溶液 (80 mL)中, 在 15~20。C下加入 IN HC1 (30 mL)。 反应在 15-20。C 下搅拌直至反应完全。 加入 100 mL乙酸乙酯, 用饱和碳酸氢钠调节水相 的 pH到 6~7。 静置分出有机相, 用 50 mL饱和食盐水洗涤, 浓縮, 硅胶 柱色谱纯化得到化学式 (lb)所示化合物 (7.16 g, 100% 产率), β/α 比为 4.2: 1。 - In an aqueous solution (80 mL), at 15-20. Add IN HC1 (30 mL) to C. The reaction is at 15-20. Stir under C until the reaction is complete. Add 100 mL of ethyl acetate and adjust the pH of the aqueous phase to 6-7 with saturated sodium bicarbonate. The organic phase was separated, washed with 50 mL of brine, concentrated, and purified by silica gel column chromatography to give the compound of formula (lb) (7.16 g, 100% yield). The ratio of β/α was 4.2:1.
^ NMR ( β异构体)(400 MHz, CDC13): δ 6.65 (brs, 1Η), 4.04-4.09 (m, 1H), 3.69 (s, 3H), 3.80 (dd, J= 6.4, 2.1 Hz, 1H), 3.69-3.75 (m, 1H), 2.85 (dd J = 6.6, 1.8 Hz, 1H), 2.65 (brs, 1H), 1.24 (d, J = 6.3 Hz, 3H), 1.17 (d, J = 6.3 Hz, 3H) o 实施例 4 ^ NMR (β isomer) (400 MHz, CDC1 3 ): δ 6.65 (brs, 1Η), 4.04-4.09 (m, 1H), 3.69 (s, 3H), 3.80 (dd, J= 6.4, 2.1 Hz , 1H), 3.69-3.75 (m, 1H), 2.85 (dd J = 6.6, 1.8 Hz, 1H), 2.65 (brs, 1H), 1.24 (d, J = 6.3 Hz, 3H), 1.17 (d, J = 6.3 Hz, 3H) o Example 4
( 1 ) 制备化学式 (Hid)所示化合物  (1) Preparation of a compound of the formula (Hid)
Figure imgf000013_0001
在约 25°C下加入邻硝基苄醇 (107 g), 3-氧代戊酸甲酯 (100 g)和甲苯
Figure imgf000013_0001
Add o-nitrobenzyl alcohol (107 g), methyl 3-oxopentanoate (100 g) and toluene at about 25 °C
(300 mL) , 加热至回流, 采用常压蒸馏装置蒸出溶剂至体系温度升至 150 °C。 重复 3~4次, 所得化学式 (XVIId)所示化合物的粗品直接用于下一步 反应。 (300 mL), heated to reflux, and the solvent was distilled off using an atmospheric distillation apparatus until the temperature of the system was raised to 150 °C. The crude product of the obtained compound of the formula (XVIId) was directly used in the next reaction 3 to 4 times.
在约 25 °C下加入上述化学式 (XVIId)所示化合物的粗品, 甲苯 (300 mL)和三乙胺 (35.4 g), 然后滴加对十二垸基苯磺酰叠氮 (270.4 g)。 滴毕, 自然恢复到室温反应 5小时。 反应体系浓縮至约 200~300 mL, 然后加入 正庚垸 (500 mL), 冰水浴冷却搅拌约 1小时。 过滤, 滤饼用正庚垸洗涤, 干燥得到化学式 (Hid)所示化合物(151 g, 产率 78%) , 液相纯度 99.6%。  The crude compound of the above formula (XVIId), toluene (300 mL) and triethylamine (35.4 g) were added at about 25 ° C, then p-dodecylbenzenesulfonyl azide (270.4 g) was added dropwise. After the completion of the dropwise addition, the reaction was naturally returned to room temperature for 5 hours. The reaction system was concentrated to about 200 to 300 mL, then n-glycol (500 mL) was added, and the mixture was cooled and cooled in an ice water bath for about 1 hour. After filtration, the filter cake was washed with n-glycol and dried to give a compound of the formula (Hd) (151 g, yield 78%), and the liquid phase purity was 99.6%.
!H NMR (400 MHz, CDC13): δ 8.08-8.18 (m, 1Η), 7.64-7.75 (m, 1H), 7.46-7.59 (m, 2H), 5.67 (s, 2H), 2.86 (q, J = 7.3 Hz, 2H), 1.15 (t, J = 7.3 Hz, 3H) o !H NMR (400 MHz, CDC1 3 ): δ 8.08-8.18 (m, 1Η), 7.64-7.75 (m, 1H), 7.46-7.59 (m, 2H), 5.67 (s, 2H), 2.86 (q, J = 7.3 Hz, 2H), 1.15 (t, J = 7.3 Hz, 3H) o
( 2 ) 制备化学式 (Id)所示化合物  (2) Preparation of a compound of formula (Id)
Figure imgf000013_0002
化学式 (Illd)所示化合物 (23.1 g)溶解于二氯甲垸 (280 mL)中, 冷却至
Figure imgf000013_0002
The compound of formula (Illd) (23.1 g) was dissolved in dichloromethane (280 mL) and cooled to
-40 °C, 缓慢加入四氯化钛 (13.2 g) ,所得的黄色浆状物继续搅拌 30分钟。 缓慢加入三乙胺 (14.1 g) , 然后反应液升至 -20°C并继续搅拌 1小时, 然后 缓慢加入 4AA (20 g)的二氯甲垸 (40 mL)溶液。 在 -20°C下搅拌 3小时后, 将反应物升温至室温, 然后用水 (150 mL)淬灭。 静置分层, 分出二氯甲垸 相, 然后浓縮得化学式 (XVId)所示化合物的粗品 44.2 Titanium tetrachloride (13.2 g) was slowly added at -40 ° C, and the resulting yellow slurry was stirred for further 30 minutes. Triethylamine (14.1 g) was slowly added, then the reaction mixture was warmed to -20 ° C and stirring was continued for 1 hour, then a solution of 4AA (20 g) of dichloromethane (40 mL) was slowly added. After stirring at -20 ° C for 3 hours, The reaction was warmed to rt then EtOAc (EtOAc)EtOAc. The mixture was allowed to stand for separation, the methylene chloride phase was separated, and then concentrated to give a crude product of the formula (XVId).
将化学式 (XVId)所示化合物的粗品 (44.2 g ) 悬浮于 50%的乙腈溶液 The crude product (44.2 g) of the compound of formula (XVId) was suspended in 50% acetonitrile solution.
(120 mL)中, 在 15~20。C下加入 3N HC1 (40 mL)。 反应在 15-20。C下搅 拌直至反应完全。加入 120 mL乙酸乙酯,用饱和碳酸氢钠调节水相的 pH 到 6~7。 静置分出有机相, 用 45 mL饱和食盐水洗涤, 浓縮, 硅胶柱色谱 纯化得到化学式 (Id)所示化合物(12.2 g, 两步 45%产率), β/α 比为 8.5: 1。 (120 mL), in 15~20. Add 3N HC1 (40 mL) to C. The reaction is at 15-20. Stir under C until the reaction is complete. 120 mL of ethyl acetate was added and the pH of the aqueous phase was adjusted to 6-7 with saturated sodium bicarbonate. The organic phase was separated, washed with 45 mL of brine, concentrated, and purified by silica gel column chromatography to give the compound of formula (Id) (12.2 g, two-step 45% yield) with a ratio of 8.5:1. .
!H NMR ( β异构体) (400 MHz, CDC13): δ 8.09 (dd, J = 8.6, 1.2 Hz, ! H NMR (β-isomer) (400 MHz, CDC1 3) : δ 8.09 (dd, J = 8.6, 1.2 Hz,
1H), 7.68 (td, J = 7.4 , 1.2 Hz), 7.53 (t, J = 7.4 Hz, 2H), 6.51 (s, 1H), 5.64 (s, 2H), 4.06-4.11 (m, 1H), 3.82 (dd, J = 6.3, 2.1 Hz, 1H), 3.70-3.76 (m, 1H),1H), 7.68 (td, J = 7.4, 1.2 Hz), 7.53 (t, J = 7.4 Hz, 2H), 6.51 (s, 1H), 5.64 (s, 2H), 4.06-4.11 (m, 1H), 3.82 (dd, J = 6.3, 2.1 Hz, 1H), 3.70-3.76 (m, 1H),
2.88 (dd, J = 6.8, 2.0 Hz, 1H), 2.67 (brs, 1H), 1.25 (d, J = 6.4 Hz, 3H), 1.182.88 (dd, J = 6.8, 2.0 Hz, 1H), 2.67 (brs, 1H), 1.25 (d, J = 6.4 Hz, 3H), 1.18
(d, J = 6.5 Hz, 3H (d, J = 6.5 Hz, 3H
实施例 Example
( 1 ) 制备化学式 (Hie)所示化合物 (1) Preparation of a compound of the formula (Hie)
Figure imgf000014_0001
在约 20 °C下加入 2, 4-二氯苄醇(124 g)、 3-氧代戊酸甲酯(100 g)和 甲苯 (300 mL), 加热至回流, 采用常压蒸馏装置蒸出溶剂至体系温度升至 150 °C。 重复 3~4次, 所得化学式 (XVIIe)所示化合物的粗品直接用于下 一步反应。
Figure imgf000014_0001
Add 2,4-dichlorobenzyl alcohol (124 g), methyl 3-oxopentanoate (100 g) and toluene (300 mL) at about 20 ° C, heat to reflux, and distill off with an atmospheric distillation apparatus. Solvent to system temperature rose to 150 °C. The crude product of the obtained compound of the formula (XVIIe) was directly used in the next reaction 3 to 4 times.
在约 20°C 下加入上述化学式 (XVIIe)所示化合物的粗品, 甲苯 (300 mL)和三乙胺 (35.4 g), 然后滴加对十二垸基苯磺酰叠氮 (270.4 g)。 滴毕, 自然恢复到室温反应 5小时。 反应体系浓縮至约 200~300 mL, 然后加入 正庚垸 (500 mL), 冰水浴冷却搅拌约 2小时。 过滤, 滤饼用正庚垸洗涤, 干燥得到化学式 (Hie)所示化合物(158 g, 产率 75%) , 液相纯度 98.9%。  The crude compound of the above formula (XVIIe), toluene (300 mL) and triethylamine (35.4 g) were added at about 20 ° C, then p-dodecylbenzenesulfonyl azide (270.4 g) was added dropwise. After the completion of the dropwise addition, the reaction was naturally returned to room temperature for 5 hours. The reaction system was concentrated to about 200 to 300 mL, then n-glycol (500 mL) was added, and the mixture was cooled and cooled in an ice water bath for about 2 hours. After filtration, the filter cake was washed with n-glycol and dried to give a compound of the formula (Hie) (158 g, yield: 75%), and the liquid phase purity was 98.9%.
!H NMR (400 MHz, CDC13): δ 7.42 (s, 1H), 7.32-7.42 (m, 1H), 7.25-7.27 (m, 1H), 5.31 (s, 2H), 2.85 (q, J = 7.3 Hz, 2H), 1.13 (t, J = 7.3 Hz, 3H ! H NMR (400 MHz, CDC1 3): δ 7.42 (s, 1H), 7.32-7.42 (m, 1H), 7.25-7.27 (m, 1H), 5.31 (s, 2H), 2.85 (q, J = 7.3 Hz, 2H), 1.13 (t, J = 7.3 Hz, 3H
(2 ) 制备化学式 (Ie)所示化合物  (2) Preparation of a compound of the formula (Ie)
Figure imgf000015_0001
化学式 (Ille)所示化合物 (25.1 g)溶解于二氯甲垸 (280 mL)中, 冷却至
Figure imgf000015_0001
The compound of formula (Ille) (25.1 g) was dissolved in dichloromethane (280 mL) and cooled to
-40°C, 缓慢加入四氯化钛 (13.2 g), 所得的黄色浆状物继续搅拌 30分钟。 缓慢加入三乙胺 (14.1 g), 然后反应液升至 -20°C并继续搅拌 1小时, 然后 缓慢加入 4AA (20 g)的二氯甲垸 (40 mL)溶液。 在 -20°C下搅拌 3小时后, 将反应物升温至室温, 然后用水 (150 mL)淬灭。 静置分层, 分出二氯甲垸 相, 然后浓縮得化学式 (XVIe)所示化合物的粗品 47.4 g。 Titanium tetrachloride (13.2 g) was slowly added at -40 ° C, and the resulting yellow slurry was stirred for further 30 minutes. Triethylamine (14.1 g) was slowly added, then the reaction mixture was warmed to -20 ° C and stirring was continued for 1 hour, then a solution of 4AA (20 g) of dichloromethane (40 mL) was slowly added. After stirring at -20 °C for 3 hours, the reaction was warmed to EtOAc EtOAc. The mixture was allowed to stand for separation, and the methylene chloride phase was separated, and then concentrated to give 47.4 g of crude compound of formula (XVI).
将化学式 (XVIe)所示化合物的粗品 (47.4 g ) 悬浮于 40%的乙腈水溶 液(120 mL)中, 在 15~20°C下加入 3N HC1 (40 mL)。 反应在 15~20 °C下 搅拌直至反应完全。 加入 120 mL乙酸乙酯, 用饱和碳酸氢钠调节水相的 pH到 6~7。 静置分出有机相, 用 45 mL饱和食盐水洗涤, 浓縮, 硅胶柱 色谱纯化得到化学式 (Ie)所示化合物(14.1 g, 两步 49%产率), β/α 比为 10  The crude compound (47.4 g) of the compound of the formula (XVIe) was suspended in 40% aqueous acetonitrile (120 mL), and 3N HCl (40 mL) was added at 15 to 20 °C. The reaction was stirred at 15 to 20 ° C until the reaction was completed. 120 mL of ethyl acetate was added and the pH of the aqueous phase was adjusted to 6-7 with saturated sodium bicarbonate. The organic phase was separated, washed with 45 mL of brine, concentrated, and purified by silica gel chromatography to give the compound of formula (Ie) (14.1 g, two-step 49% yield) with a ratio of β/α of 10
!H NMR ( β异构体) (400 MHz, CDC13): δ 7.38 (ά, J = 2.0 Hz, 1H), 7.30 (d, J = 8.2 Hz, 1H), 7.23 (dd, J = 8.2, 2.0 Hz, 1H), 6.74 (s, 1H), 5.28 (s, 2H), 4.04-4.09 (m, 1H), 3.80 (dd, J = 6.4, 2.1 Hz, 1H), 3.69-3.75 (m, 1H), 3.36 (brs, 1H), 2.85 (dd, J = 6.6, 1.8 Hz, 1H), 1.22 (d, J = 6.9 Hz, 3H), 1.17 (d, J = 6.9 Hz, 3H ! H NMR (β-isomer) (400 MHz, CDC1 3) : δ 7.38 (ά, J = 2.0 Hz, 1H), 7.30 (d, J = 8.2 Hz, 1H), 7.23 (dd, J = 8.2, 2.0 Hz, 1H), 6.74 (s, 1H), 5.28 (s, 2H), 4.04-4.09 (m, 1H), 3.80 (dd, J = 6.4, 2.1 Hz, 1H), 3.69-3.75 (m, 1H ), 3.36 (brs, 1H), 2.85 (dd, J = 6.6, 1.8 Hz, 1H), 1.22 (d, J = 6.9 Hz, 3H), 1.17 (d, J = 6.9 Hz, 3H
以上特别说明和描述了具体实施方式。 对于本领域普通技术人员而 言, 所述公开不限于实施方式, 在所附权利要求书的精神和范围内, 所有 适当的修饰或等同替换都将落入所述公开的范围之内。  The specific embodiments have been particularly described and described above. It is intended that the present invention is not to be construed as being limited by the scope of the disclosure.

Claims

权利要求 Rights request
1. 一种制备培南类抗生素中间体的方法, 其特征在于, 包括以下步 骤: 1. A method for preparing penem antibiotic intermediates, characterized in that it includes the following steps:
步骤 1 : 由化学式 σι)所示化合物与化学式 σιι)所示化合物反应得到 化学式 (XVI)所示化合物; Step 1: The compound represented by chemical formula (XVI) is obtained by reacting the compound represented by chemical formula σί) and the compound represented by chemical formula σί);
步骤 2 : 由所述化学式 (XVI)所示化合物制备化学式 所示的培南类 抗生素中间体; Step 2: Prepare the penem antibiotic intermediate represented by the chemical formula from the compound represented by the chemical formula (XVI);
所述方法合成路线如下: The synthetic route of the method is as follows:
Figure imgf000016_0001
Figure imgf000016_0001
II III XVI 其中, R1代表甲基、 乙基、 对硝基苄基、 苄基、 烯丙基、 4-氯苄基、 2-硝基苄基、 3-硝基苄基或 4-甲氧基苄基; R2代表乙酰基或苯甲酰基; II III Oxybenzyl; R 2 represents acetyl or benzoyl;
R3代表三甲基硅基或叔丁基二甲基硅基。 R 3 represents trimethylsilyl or tert-butyldimethylsilyl.
2. 根据权利要求 1的方法, 其特征在于, 所述步骤 1的反应在路易 斯酸催化的直接曼尼奇反应条件下进行。 2. The method according to claim 1, characterized in that the reaction of step 1 is carried out under direct Mannich reaction conditions catalyzed by Lewis acid.
3. 根据权利要求 2的方法, 其特征在于, 所述用于曼尼奇反应的路 易斯酸选自四氯化钛、 四溴化钛、 四氯化硅、 三氯化镧、 氯化锌、 溴化 锌、 氯化镁、 三溴化硼、 氯化铜、 三氟甲磺酸铜、 三氟甲磺酸亚铜、 碘 化亚铜或三氯化硼, 优选四氯化钛。 3. The method according to claim 2, characterized in that the Lewis acid used for Mannich reaction is selected from titanium tetrachloride, titanium tetrabromide, silicon tetrachloride, lanthanum trichloride, zinc chloride, Zinc bromide, magnesium chloride, boron tribromide, copper chloride, copper triflate, copper triflate, copper iodide or boron trichloride, preferably titanium tetrachloride.
4. 根据权利要求 3的方法, 其特征在于, 所述路易斯酸与所述化学 式 (II)所示化合物的摩尔比为 0.8~3.0: 1, 优选 1.0~1.5: 1。 4. The method according to claim 3, characterized in that the molar ratio of the Lewis acid to the compound represented by the chemical formula (II) is 0.8~3.0:1, preferably 1.0~1.5:1.
5. 根据权利要求 2的方法, 其特征在于, 所述步骤 1的反应中还存 在路易斯碱, 其选自三乙胺、 二异丙基乙胺、 三丁胺、 四甲基乙二胺、 4-甲基吗啉、 1,8-二氮杂双环 [5.4.0] ^—碳 -7-烯、 1,4-二氮杂二环 [2.2.2] 辛垸、 4-二甲胺基吡啶、 N-甲基吡咯垸、 N-甲基哌啶、 二乙胺、 二异丙 胺、 吡咯、 哌啶、 六甲基磷酰三胺、 吡啶、 3-甲基吡啶或它们的组合, 优选其中的三级胺。 5. The method according to claim 2, characterized in that a Lewis base also exists in the reaction of step 1, which is selected from the group consisting of triethylamine, diisopropylethylamine, tributylamine, tetramethylethylenediamine, 4-methylmorpholine, 1,8-diazabicyclo[5.4.0]-carbon-7-ene, 1,4-diazabicyclo[2.2.2]octane, 4-dimethylamine Pyridine, N-methylpyrrole, N-methylpiperidine, diethylamine, diisopropyl Amine, pyrrole, piperidine, hexamethylphosphoric triamide, pyridine, 3-methylpyridine or combinations thereof, with tertiary amines among them being preferred.
6. 根据权利要求 5的方法, 其特征在于, 所述路易斯碱与所述化学 式 (II)所示化合物的摩尔比为 1.2~4.0: 1, 优选 1.8~2.5: 1。 6. The method according to claim 5, characterized in that the molar ratio of the Lewis base and the compound represented by the chemical formula (II) is 1.2~4.0:1, preferably 1.8~2.5:1.
7. 根据权利要求 2的方法, 其特征在于, 所述步骤 1的反应在溶剂 中进行, 所述溶剂选自二氯甲垸、 1,2-二氯乙垸、 甲苯、 乙腈、 四氢呋喃、 甲基叔丁基醚、 2-甲基四氢呋喃或它们的组合, 优选二氯甲垸、 1,2-二氯 乙垸或它们的组合; 所述溶剂的用量为每克所述化学式 (Π)所示化合物使 用 8~30 mL, 优选为每克所述化学式 (II)所示化合物使用 12~20 mL。 7. The method according to claim 2, characterized in that the reaction of step 1 is carried out in a solvent, and the solvent is selected from the group consisting of dichloromethane, 1,2-dichloroethane, toluene, acetonitrile, tetrahydrofuran, and methane. tert-butyl ether, 2-methyltetrahydrofuran or a combination thereof, preferably dichloromethane, 1,2-dichloroethane or a combination thereof; the amount of the solvent is 1 gram of the chemical formula (II) 8 to 30 mL of the compound represented by the chemical formula (II) is used, preferably 12 to 20 mL per gram of the compound represented by the chemical formula (II).
8. 根据权利要求 2的方法, 其特征在于, 所述化学式 (ΙΠ)所示化合 物与所述化学式 (Π)所示化合物的摩尔比为 1.0~2.0 : 1, 优选 1.2~1.5: 1。 8. The method according to claim 2, characterized in that the molar ratio of the compound represented by the chemical formula (ΙΠ) and the compound represented by the chemical formula (Π) is 1.0~2.0:1, preferably 1.2~1.5:1.
9. 根据权利要求 2的方法, 其特征在于, 所述步骤 1的反应温度为 -60~10。C, 优选 -30~0 °C。 9. The method according to claim 2, characterized in that the reaction temperature of step 1 is -60~10. C, preferably -30~0°C.
10. 根据权利要求 2的方法, 其特征在于, 所述步骤 1反应完成后, 采用以下淬灭溶液淬灭反应: 氯化钠溶液、 碳酸氢钠溶液、 磷酸二氢钠 溶液、 磷酸二氢钾溶液、 氯化镁溶液、 氯化钙溶液或纯水, 优选纯水; 所述淬灭溶液的用量为每克所述化学式 (II)所示化合物使用 3~30 mL, 优 选为每克所述化学式 (Π)所示化合物使用 5~10 mL。 10. The method according to claim 2, characterized in that, after the reaction in step 1 is completed, the following quenching solution is used to quench the reaction: sodium chloride solution, sodium bicarbonate solution, sodium dihydrogen phosphate solution, potassium dihydrogen phosphate solution, magnesium chloride solution, calcium chloride solution or pure water, preferably pure water; the dosage of the quenching solution is 3 to 30 mL per gram of the compound represented by the chemical formula (II), preferably 3 to 30 mL per gram of the chemical formula (II) Use 5~10 mL of the compound shown in Π).
11. 根据权利要求 1的方法, 其特征在于, 所述步骤 2的反应在采用 酸催化脱除三甲基硅基或叔丁基二甲基硅基的反应条件下进行。 11. The method according to claim 1, characterized in that the reaction in step 2 is carried out under the reaction conditions of acid-catalyzed removal of trimethylsilyl or tert-butyldimethylsilyl.
12. 根据权利要求 11的方法, 其特征在于, 所述酸选自盐酸、 硫酸、 甲基磺酸、 苯磺酸或三氟乙酸, 优选盐酸。 12. The method according to claim 11, characterized in that the acid is selected from hydrochloric acid, sulfuric acid, methylsulfonic acid, benzenesulfonic acid or trifluoroacetic acid, preferably hydrochloric acid.
13. 根据权利要求 12 的方法, 其特征在于, 所述酸的浓度为 0.5~4 mol/L, 优选为 1.0~2.0 mol/L。 13. The method according to claim 12, characterized in that the concentration of the acid is 0.5~4 mol/L, preferably 1.0~2.0 mol/L.
14. 根据权利要求 11的方法, 其特征在于, 所述步骤 2的反应在溶 剂中进行, 所述溶剂选自乙腈 -水、 甲醇 -水、 丙酮-水或四氢呋喃 -水, 优 选乙腈 -水。 14. The method according to claim 11, characterized in that the reaction of step 2 is carried out in a solvent It is carried out in a solvent selected from acetonitrile-water, methanol-water, acetone-water or tetrahydrofuran-water, preferably acetonitrile-water.
15. 根据权利要求 11的方法, 其特征在于, 所述步骤 2的反应温度 为 0~30°C, 优选 15~20°C。 15. The method according to claim 11, characterized in that the reaction temperature of step 2 is 0~30°C, preferably 15~20°C.
PCT/CN2013/087038 2013-11-13 2013-11-13 Method for preparing penem antibiotic intermediate WO2015070394A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2013/087038 WO2015070394A1 (en) 2013-11-13 2013-11-13 Method for preparing penem antibiotic intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2013/087038 WO2015070394A1 (en) 2013-11-13 2013-11-13 Method for preparing penem antibiotic intermediate

Publications (1)

Publication Number Publication Date
WO2015070394A1 true WO2015070394A1 (en) 2015-05-21

Family

ID=53056616

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2013/087038 WO2015070394A1 (en) 2013-11-13 2013-11-13 Method for preparing penem antibiotic intermediate

Country Status (1)

Country Link
WO (1) WO2015070394A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105315299A (en) * 2015-09-22 2016-02-10 盐城开元医药化工有限公司 Synthesis method of ceftizoxime mother nucleus 7-ANCA
CN105906529A (en) * 2016-06-07 2016-08-31 江西富祥药业股份有限公司 4-halogenated-2-diazo-3-oxo-valeric acid(4-nitrobenzene)methyl ester and preparation method thereof
CN117186116A (en) * 2023-09-07 2023-12-08 浙江荣耀生物科技股份有限公司 Preparation method of cefvicin intermediate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4841043A (en) * 1985-12-23 1989-06-20 Bristol-Myers Company Stereoselective synthesis of 1-β-alkyl carbapenem antibiotic intermediates
CN1610663A (en) * 2002-03-25 2005-04-27 高砂香料工业株式会社 The preparation method of azetidinone compound
CN102936217A (en) * 2012-11-08 2013-02-20 浙江新东港药业股份有限公司 Preparation method of intermediate for penem

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4841043A (en) * 1985-12-23 1989-06-20 Bristol-Myers Company Stereoselective synthesis of 1-β-alkyl carbapenem antibiotic intermediates
CN1610663A (en) * 2002-03-25 2005-04-27 高砂香料工业株式会社 The preparation method of azetidinone compound
CN102936217A (en) * 2012-11-08 2013-02-20 浙江新东港药业股份有限公司 Preparation method of intermediate for penem

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105315299A (en) * 2015-09-22 2016-02-10 盐城开元医药化工有限公司 Synthesis method of ceftizoxime mother nucleus 7-ANCA
CN105315299B (en) * 2015-09-22 2017-06-27 盐城开元医药化工有限公司 A kind of synthetic method of the ANCA of Ceftizoxime parent nucleus 7
CN105906529A (en) * 2016-06-07 2016-08-31 江西富祥药业股份有限公司 4-halogenated-2-diazo-3-oxo-valeric acid(4-nitrobenzene)methyl ester and preparation method thereof
CN105906529B (en) * 2016-06-07 2018-11-27 江西富祥药业股份有限公司 Halogenated -2- diazonium -3- the oxo-pentanoic acid of 4- (4- nitrobenzene) methyl esters and preparation method thereof
CN117186116A (en) * 2023-09-07 2023-12-08 浙江荣耀生物科技股份有限公司 Preparation method of cefvicin intermediate
CN117186116B (en) * 2023-09-07 2024-06-07 浙江荣耀生物科技股份有限公司 Preparation method of cefvicin intermediate

Similar Documents

Publication Publication Date Title
JP5784602B2 (en) Process for the production of pharmaceutically active compounds
TW202016077A (en) Novel processes
CN102424686A (en) Process for the preparation of high-purity prasugrel hydrochloride
WO2015070394A1 (en) Method for preparing penem antibiotic intermediate
CN101967118B (en) Preparation method of alvimopan
WO2017163257A1 (en) Process for preparing pure lh-pyrazolo[3,4-d] pyrimidine derivative
CN115819319A (en) A kind of amide compound, its preparation method and its application
CA2537536A1 (en) Process for the preparation of renzapride and intermediates thereof
EP3911660B1 (en) Process for preparation of 2-amino-5-hydroxy propiophenone
CN103553995A (en) Method for preparing penem antibiotic midbody
US6921839B2 (en) Synthesis of N,N-dimethyl-3-(4-methyl) benzoyl propionamide a key intermediate of zolpidem
JPWO2008020597A1 (en) Method for producing 1-methylcarbapenem intermediate
JPH10502620A (en) Preparation of alkylating agents and their use for alkylating cyclic ureas
CN112321398B (en) Method for synthesizing alpha-fluorinated ketone by hydrazonating aliphatic chain monoketone
JP3184345B2 (en) Method for producing 5-chlorooxindole
CN1414959A (en) Process for production of 5-oxy-7-oxabicyclo-[4.1.0]hept-3-ENE-3-carboxylic acid esters
JPH01311060A (en) 3, 4-dihydroxy-2-pyroliginone derivative
JP3238512B2 (en) Method for producing sulfamides
Eagles et al. Synthesis of d-camphor based γ-amino acid (1S, 3R)-3-amino-2, 2, 3-trimethylcyclopentane carboxylic acid
TW202513046A (en) Process for the preparation of preparing 1-ethyl-n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)piperidine-4-sulfonamide
Meiries et al. Synthesis of the trichloroacetamide derivative of enantio-iso-ADDA methyl ester
WO2014147464A2 (en) Novel process for the preparation of tolcapone
JPH05221947A (en) Production of cyclopropane derivative
JP3418725B2 (en) Simple method for producing 1,1-bis (4-aminophenyl) ethane
JPH0812658A (en) Production of sydnones

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13897558

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13897558

Country of ref document: EP

Kind code of ref document: A1